兴齐眼药1月16日获融资买入1.37亿元，融资余额12.62亿元

Group 1 - On January 16, Xingqi Eye Pharmaceutical's stock rose by 1.89% with a trading volume of 899 million yuan [1] - The financing data shows that on the same day, the company had a financing purchase amount of 137 million yuan and a financing repayment of 110 million yuan, resulting in a net financing purchase of 27.59 million yuan [1] - As of January 16, the total balance of margin trading for Xingqi Eye Pharmaceutical was 1.268 billion yuan, with a financing balance of 1.262 billion yuan, accounting for 6.54% of the circulating market value, which is above the 90th percentile level over the past year [1] Group 2 - As of September 30, the number of shareholders of Xingqi Eye Pharmaceutical reached 54,100, an increase of 16.85% compared to the previous period [2] - For the period from January to September 2025, the company achieved an operating income of 1.904 billion yuan, a year-on-year increase of 32.27%, and a net profit attributable to shareholders of 599 million yuan, a year-on-year increase of 105.98% [2] - Since its A-share listing, Xingqi Eye Pharmaceutical has distributed a total of 1.166 billion yuan in dividends, with 985 million yuan distributed over the past three years [2]